Should You Add MIS To Your Spine Implant Catalog?

A hospital procurement contact calls and asks if you carry a minimally invasive pedicle screw system. You currently distribute open fusion systems — SecuFix or ValuFix-type rod-screw constructs — and they've been selling fine. Now you're wondering whether adding an MIS line is worth the investment, or whether it's a distraction from a product category that already works.

This comes up more than distributors expect. Surgeon preference is shifting in a lot of markets, but not uniformly, and not for every procedure. Before adding SKUs, it helps to understand what's actually different — clinically and commercially — between the two approaches.

What "MIS" Actually Changes in the Operating Room

The term gets used loosely, so it's worth being precise. A true MIS pedicle screw system isn't just a smaller version of an open system. The core differences are:

• Percutaneous screw insertion — screws go in through small skin incisions guided by fluoroscopy, rather than through a single open exposure with retracted muscle
• Pre-bent or reduction-tab rods — the rod is passed through a cannulated extension tower system rather than laid directly into an open field, which is why MIS rod systems are often pre-curved
• Cannulated, fenestrated screws — hollow screw shafts allow guidewire-based insertion and sometimes cement augmentation in osteoporotic bone
• Tubular retractor or extension tower instrumentation — this is the instrument set that makes percutaneous placement possible, and it's the part distributors often underestimate in terms of cost and complexity

Open systems skip all of this. The surgeon has direct visualization, standard pedicle finders and taps, and a straight or slightly contoured rod that gets manually reduced into place. It's a more established workflow with a shallower learning curve.

The Clinical Trade-offs Surgeons Actually Care About

Distributors don't need to become spine surgeons, but understanding what drives surgeon preference helps you have a credible conversation with procurement and OR staff.

MIS approaches generally reduce blood loss, muscle trauma, and hospital length of stay for appropriate candidates — typically 1-2 level degenerative cases without significant deformity. That's a real clinical benefit and it's why demand exists.

But MIS isn't universally better. Multi-level constructs, revision surgery, significant deformity correction, and cases requiring wide decompression are still frequently done open, because visualization and access matter more than incision size in those scenarios. A surgeon doing primarily complex deformity work may have almost no use for an MIS screw system. A surgeon doing high-volume degenerative disease in a same-day surgery center might use almost nothing else.

This is the first thing to figure out before you commit inventory: what does your surgeon base actually operate on? Adding an MIS line to serve one deformity-focused surgeon's occasional 1-level case is a very different decision than adding it because three surgeons at your top-volume hospital are asking for it weekly.

Where the Real Cost Difference Shows Up — And It's Not the Implant

Here's what catches distributors off guard: the per-unit implant cost between MIS and open pedicle screw systems isn't dramatically different. The cost difference is in instrumentation.

An MIS system requires extension towers, guidewires, cannulated taps, percutaneous rod passers, and often a separate fluoroscopy-compatible instrument tray from the open system. You're not just adding implant SKUs — you're adding a full instrument set that has its own sterilization cycle, its own tray management, and its own capital cost if you're providing consignment instruments to hospitals.

For a distributor already running open-system inventory, this means:

• A separate instrument tray to track, sterilize, and maintain (or provide as loaner sets)
• Additional training time for OR staff on tower assembly and percutaneous workflow
• Potentially higher upfront capital if you're financing instrument sets for hospital trial periods
• Slower case-to-case turnover if you only have one MIS tray covering multiple accounts

This is why some distributors who add MIS lines end up disappointed with the margin — not because the implant pricing is bad, but because they underestimated the instrument logistics.

Side-by-Side: What Changes for Your Business

Reimbursement Doesn't Always Reward MIS the Way Surgeons Expect

This is worth raising directly with hospital contacts before you commit to a product line, because it varies a lot by market. In some countries and payer systems, the DRG or bundled payment for a fusion case is the same whether it's done open or MIS — the hospital gets paid the same amount, but the MIS case may require more expensive disposables (extension towers, guidewires) and possibly navigation fees. That squeezes hospital margin even though the patient outcome is often better.

In markets where private insurers or self-pay patients cover a premium for minimally invasive technique, hospitals have a clearer financial incentive to adopt MIS. In markets with flat bundled reimbursement, adoption is driven almost entirely by surgeon preference and OR efficiency, not hospital margin.

Before pitching MIS instrumentation to a hospital, it's worth understanding which side of that line your market falls on. A distributor who assumes MIS is automatically a hospital's preferred economic choice can get an unexpectedly cold response from a materials management team focused on per-case cost.

A Middle Path: Hybrid Adoption

Most distributors who successfully add MIS don't replace their open system — they run both, and let case selection determine which one gets used. This is also usually how surgeons themselves operate: MIS for straightforward 1-2 level cases, open for anything more complex.

Practically, this means:

• Keep your existing open rod-screw system as the primary catalog line for complex cases
• Add MIS instrumentation only once you have at least one or two surgeons with genuine, recurring demand — not speculative interest
• Negotiate instrument tray terms (consignment vs. purchase) carefully, since this is where MIS margin actually gets made or lost
• Budget real training time — for your sales reps as much as for OR staff — since MIS case support requires more hands-on presence during early adoption

Manufacturers offering both open systems (such as rod-screw constructs like SecuFix or ValuFix-type platforms) and a compatible MIS line — with instruments designed to share screw geometry and rod diameter across both — make this transition considerably easier than juggling implants from two unrelated suppliers. Cross-compatible screw and rod specifications mean your inventory doesn't fragment into two incompatible systems, and your sales team only has to learn one screw-driver interface instead of two.

Questions Worth Asking Before You Commit Inventory

• How many surgeons in my current accounts are actively asking for MIS, versus how many have mentioned it in passing?
• What percentage of their case volume would realistically shift to MIS — is it 10% of cases or 60%?
• Can I get a consignment instrument tray from the manufacturer for a trial period before purchasing outright?
• Does the MIS screw system share geometry with my existing open system, or are these two completely separate inventories to manage?
• What does the manufacturer's training and case support look like for the first 10-15 cases?

If you can't get comfortable answers to the first two questions, it's usually better to wait. Adding a product line based on one enthusiastic surgeon conversation, without checking whether that translates into real case volume, is one of the more common ways distributors end up with underused inventory sitting in a tray on a shelf.

For distributors currently evaluating MIS pedicle screw options alongside their existing spine catalog, reviewing compatible MIS Spinal Fixation Systems that cover both open and MIS constructs can simplify this decision — particularly when screw geometry and rod specifications are shared across both product lines rather than requiring entirely separate inventories.